Asthma medications not working? Try another


Annals of Allergy Asthma & Immunology

The title of the article

Biological Use and Outcomes in Adults with Severe Asthma Treated by US Subspecialists

Conflict of Interest Statement

Reynold A. Panettieri, Jr. is a member of advisory boards and has received grants from AstraZeneca, Sanofi, Genentech, Regeneron and Novartis. Dennis K. Ledford has consulted for AstraZeneca and GlaxoSmithKline and has received speaker fees from ALK, AstraZeneca, Boehringer Ingelheim, Genentech/Roche, GlaxoSmithKline, Novartis, and Sanofi/Regeneron. Bradley Chipps is an advisory board member and consultant and speaker for AstraZeneca, Boehringer Ingelheim, Genentech, Novartis, Regeneron, Sanofi Genzyme. Weily Soong is a consultant and receives grants from AstraZeneca, Genentech, GlaxoSmithKline, Avillion, Novartis, Regeneron, Sanofi, Leo and Teva, and is a speaker for AstraZeneca, GlaxoSmithKline, Regeneron, Sanofi and Optinose. Njira Lugogo has received consulting fees for serving on the advisory board of Amgen, AstraZeneca, Genentech, GlaxoSmithKline, Novartis, Regeneron, Sanofi and Teva; honoraria for presentations from the GlaxoSmithKline and Astra Zeneca Non-Speakers Bureau; and Astra Zeneca travel assistance; his institution has received research support from Amgen, AstraZeneca, Avillion, Gossamer Bio, Genentech, GlaxoSmithKline, Regeneron, Sanofi and Teva. Warner W. Carr is a speaker for AstraZeneca, Teva, Boehringer Ingelheim, Regeneron, and Sanofi, and a consultant for AstraZeneca, Teva, Boehringer Ingelheim, Regeneron, Sanofi, Circassia, CSL Behring, Genentech, GlaxoSmithKline, Horizon Pharma, Kaleo, Mylan, Pfizer, Shire, Meda, Baxalta, Novartis, Greer Laboratories, Alcon Laboratories, Valeant Pharmaceuticals, Grifols, Optinose and Aerocrine. Arjun Mohan did not divulge anything. Donna Carstens, Eduardo Genofre, Frank Trudo and Christopher S. Ambrose are employees and shareholders of AstraZeneca.

About Margie Peters

Check Also

Global Psychedelic Drugs Market Report 2022

New York, July 29. 2022 (GLOBE NEWSWIRE) — Announces Release of “Psychedelic Drugs Global …